Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    20965785 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
Condition: Leukemia, Chronic Myeloid
Interventions: Drug: Pioglitazone;   Other: imatinib discontinuation
2 Recruiting Malaysia Stop Tyrosine Kinase Inhibitor Trial
Condition: Leukemia, Chronic Myeloid
Intervention: Drug: Peginterferon-α-2a
3 Completed Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
Condition: Myeloid Leukemia, Chronic
Intervention: Behavioral: Imatinib ending

Indicates status has not been verified in more than two years